4.60Open4.60Pre Close0 Volume2 Open Interest20.00Strike Price0.00Turnover268.88%IV-53.39%PremiumMay 16, 2025Expiry Date9.96Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7765Delta0.0471Gamma0.95Leverage Ratio-0.0448Theta-0.0081Rho-0.74Eff Leverage0.0071Vega
TYRA BIOSCIENCES, INC. Stock Discussion
Tyra Bio Achieves 54.5% Response Rate in Cancer Trial, Secures 3-Year Runway
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$